• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE ALPINE; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE ALPINE; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1128350-15
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Arrest (1762); Ischemia (1942); Cardiogenic Shock (2262)
Event Date 09/06/2019
Event Type  Death  
Manufacturer Narrative
Exemption number (b)(4).The device remains in the patient.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.The xience proa device is currently not commercially available in the u.S.; however, it is similar to a device sold in the us.
 
Event Description
It was reported that the procedure was performed to treat a proximal left anterior descending (lad) lesion.The 3.50x15mm xience proa stent was implanted successfully.A few hours later, the patient had cardiac shock and needed to be resuscitated.The patient was returned to the cath lab and it was noted there was reduced blood flow in the distal lad.The lesion was dilated using a non-abbott balloon then a 2.75x33mm xience pro stent was placed.The perfusion was restored successfully but due to the cardiogenic shock the circulation couldn't be fully restored, and the patient died.According to the physician the patient died due to protracted cardiogenic shock.In the physician¿s opinion the death was because of the general condition of the patient and not because of the placed stents.No additional information was provided.
 
Manufacturer Narrative
Exemption number e2019001.The device was not returned for evaluation.The reported patient effects of death and ischemia are listed in the xience pro a everolimus eluting coronary stent systems instructions for use, as a known patient effects of coronary stenting procedures a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Event Description
It was reported that the procedure was performed to treat a proximal left anterior descending (lad) lesion.The 3.50x15mm xience proa stent was implanted successfully.A few hours later, the patient had a cardiac shock and needed to be resuscitated.The patient was returned to the cath lab and it was noted there was reduced blood flow in the distal lad.The lesion was dilated using a non-abbott balloon then a 2.75x33mm xience pro stent was placed.The perfusion was restored successfully but due to the cardiogenic shock the circulation couldn't be fully restored, and the patient died.According to the physician the patient died due to a protracted cardiogenic shock.In the physician¿s opinion the death was because of the general condition of the patient and not because of the placed stents.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE ALPINE
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key9158545
MDR Text Key161276037
Report Number2024168-2019-12376
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/04/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/04/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/01/2022
Device Catalogue Number1128350-15
Device Lot Number9041861
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/11/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/02/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
-
-